Trial: 202112114

A Pilot Study of Enasidenib for Patients with Clonal Cytopenia of Undetermined Significance and Mutations in IDH2

Phase

I

Principal Investigator

Bolton, Kelly

Disease Site

Myeloid and Monocytic Leukemia; Other Hematopoietic

Learn more about this study at: clinicaltrials.gov